mitoxantrone has been researched along with Enlarged Liver in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Visani, G | 1 |
| Bernasconi, P | 1 |
| Boni, M | 1 |
| Castoldi, GL | 1 |
| Ciolli, S | 1 |
| Clavio, M | 1 |
| Cox, MC | 1 |
| Cuneo, A | 1 |
| Del Poeta, G | 1 |
| Dini, D | 1 |
| Falzetti, D | 1 |
| Fanin, R | 1 |
| Gobbi, M | 1 |
| Isidori, A | 1 |
| Leoni, F | 1 |
| Liso, V | 1 |
| Malagola, M | 1 |
| Martinelli, G | 1 |
| Mecucci, C | 1 |
| Piccaluga, PP | 1 |
| Petti, MC | 1 |
| Rondelli, R | 1 |
| Russo, D | 1 |
| Sessarego, M | 1 |
| Specchia, G | 1 |
| Testoni, N | 1 |
| Torelli, G | 1 |
| Mandelli, F | 1 |
| Tura, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission[NCT01050036] | 39 participants (Anticipated) | Interventional | 2010-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mitoxantrone and Enlarged Liver
| Article | Year |
|---|---|
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromoso | 2001 |